Revenue | ₹651.10Cr |
Net Profits | ₹133Cr |
Net Profit Margins | 20.43% |
Natco Pharma Ltd’s revenue fell -18.16% since last year same period to ₹651.10Cr in the Q3 2024-2025. On a quarterly growth basis, Natco Pharma Ltd has generated -54.62% fall in its revenue since last 3-months.
Natco Pharma Ltd’s net profit fell -37.47% since last year same period to ₹133Cr in the Q3 2024-2025. On a quarterly growth basis, Natco Pharma Ltd has generated -80.36% fall in its net profits since last 3-months.
Natco Pharma Ltd’s net profit margin fell -23.59% since last year same period to 20.43% in the Q3 2024-2025. On a quarterly growth basis, Natco Pharma Ltd has generated -56.72% fall in its net profit margins since last 3-months.
The revenue for Natco Pharma Ltd in the Q3 results 2024 was ₹651.10Cr.
The net profit for Natco Pharma Ltd in the Q3 results 2024 was ₹133Cr.
The net profit margin for Natco Pharma Ltd in the Q3 results 2024 was 20.43%.
The revenue for Natco Pharma Ltd in the Q3 results 2023 was ₹795.60Cr.
The net profit for Natco Pharma Ltd in the Q3 results 2023 was ₹212.70Cr.
The net profit margin for Natco Pharma Ltd in the Q3 results 2023 was 26.73%.